http://www.fpnotebook.com/
Extended Spectrum Macrolide
Aka: Extended Spectrum Macrolide, Azithromycin, Zithromax, Clarithromycin, Biaxin, Telithromycin, Ketek- See also
- Pharmacokinetics: Half Life
- Clarithromycin: 5 hours
- Telithromycin: 10 hours
- Azithromycin: 68 hours
- Dosing: Azithromycin (Zithromax)
- Directions
- Take more than 1 hour before or 2 hours after food
- Adult
- Day 1: 500 mg PO qd
- Day 2 to 5: 250 mg PO qd
- Child
- Day 1: 10 mg/kg PO qd (maximum: 500 mg)
- Day 2 to 5: 5 mg/kg PO qd (maximum: 250 mg)
- Infant under age 6 months
- 10 mg/kg/day for 5 days
- New preparations
- Directions
- Dosing: Clarithromycin (Biaxin)
- May take with or without food
- Adult: 250 to 500 mg PO bid
- Child: 7.5 mg/kg PO bid
- Dosing: Telithromycin
- Adult: 800 mg PO daily
- Course
- Acute Exacerbation of Chronic Bronchitis: 5 days
- Acute Sinusitis: 5 days
- Community acquired Pneumonia: 7 days
- Adverse effects
- Less Nausea and Vomiting than with Erythromycin
- Clarithromycin perverts sense of taste in 20%
- Indications: Major indications for newer broad spectrum Macrolides
- Erythromycin not tolerated
- Single dose Chlamydia trachomatis treatment
- Respiratory infections
- Otitis Media (Azithromycin)
- Community Acquired Pneumonia
- Consider Doxycycline as alternative
- Acute Sinusitis (Azithromycin)
- Not recommended due to growing resistance rates
- Non-tuberculous Mycobacterial infections
- Helicobacter infections
- Contraindications
- Telithromycin (Ketek) may cause repiratory failure in Myasthenia Gravis (FDA Black Box Warning)
- Preparations: Activity Spectrum
- Macrolide resistance is increasing
- Resistance to one Macrolide is resistance to all
- Spectrum includes organisms covered by Erythromycin
- Clarithromycin
- Azithromycin
- HaemophilusInfluenzae
- Moraxella catarrhalis
- Toxoplasmosis gondii
- Mycobacterium Avium Complex (Clarithromycin better)
- Borrelia Burgdorferi
- Telithromycin
- Avoid in patients with Myasthenia Gravis due to risk of respiratory failure (FDA Black Box Warning)
- Similar to other Extended Spectrum Macrolides
- Appears to have greater activity for pneumococcus
- May be used in place of other broad spectrum agents
- Augmentin
- Extended spectrum Fluoroquinolones
- References
- Macrolide resistance is increasing
| Medication Costs | ||
|---|---|---|
| Azithromycin (on 2/9/2012 at DrugStore.com) | ||
| Azithromycin 250mg Tablets | #30 for $98.99 | ($3.30/unit) |
| Azithromycin 6 250mg Tablets Disp Pack | #1 for $26.02 | ($26.02/unit) |
| Azithromycin 600mg Tablets | #30 for $399.94 | ($13.33/unit) |
| Azithromycin 500mg Tablets | #30 for $439.98 | ($14.67/unit) |
| Azithromycin 200mg/5ml Suspension 15ml Bottle | #1 for $32.99 | ($32.99/unit) |
| Zithromax (on 2/9/2012 at DrugStore.com) | ||
| Zithromax 3 1gm Packets Box | #1 for $127.99 | ($127.99/unit) |
| Zithromax 250mg Tablets | #30 for $346.00 | ($11.53/unit) |
| Zithromax 500mg Tablets | #30 for $675.99 | ($22.53/unit) |
| Zithromax 600mg Tablets | #30 for $721.18 | ($24.04/unit) |
| Zithromax 100mg/5ml Suspension 15ml Bottle | #1 for $49.99 | ($49.99/unit) |
| Zithromax 200mg/5ml Suspension 15ml Bottle | #1 for $53.99 | ($53.99/unit) |
| Zithromax 200mg/5ml Suspension 30ml Bottle | #1 for $55.99 | ($55.99/unit) |
| Zithromax Z-Pak (on 2/9/2012 at DrugStore.com) | ||
| Zithromax Z-Pak 6 250mg Tablets Disp Pack | #1 for $70.99 | ($70.99/unit) |
| Zithromax Tri-Pak (on 2/9/2012 at DrugStore.com) | ||
| Zithromax Tri-Pak 3 500mg Tablets Disp Pack | #1 for $73.99 | ($73.99/unit) |
| Clarithromycin (on 2/9/2012 at DrugStore.com) | ||
| Clarithromycin 500mg Tablets | #30 for $125.99 | ($4.20/unit) |
| Clarithromycin 250mg Tablets | #30 for $148.99 | ($4.97/unit) |
| Clarithromycin 500mg 24 Hour Tablets | #60 for $295.99 | ($4.93/unit) |
| Clarithromycin 125mg/5ml Suspension 50ml Bottle | #1 for $27.99 | ($27.99/unit) |
| Clarithromycin 125mg/5ml Suspension 100ml Bottle | #1 for $39.99 | ($39.99/unit) |
| Clarithromycin 250mg/5ml Suspension 50ml Bottle | #1 for $42.99 | ($42.99/unit) |
| Clarithromycin 250mg/5ml Suspension 100ml Bottle | #1 for $79.99 | ($79.99/unit) |
| Biaxin (on 2/9/2012 at DrugStore.com) | ||
| Biaxin 500mg Tablets | #20 for $129.98 | ($6.50/unit) |
| Biaxin 60 250mg Tablets Bottle | #1 for $361.00 | ($361.00/unit) |
| Biaxin XL (on 2/9/2012 at DrugStore.com) | ||
| Biaxin XL 500mg 24 Hour Tablets | #20 for $135.00 | ($6.75/unit) |
| Ketek (on 2/9/2012 at DrugStore.com) | ||
| Ketek 400mg Tablets | #60 for $311.99 | ($5.20/unit) |
| FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. | ||
Azithromycin (C0052796) |
|
|---|---|
| Definition (CHV) | a kind of antibiotic drug |
| Definition (CHV) | a kind of antibiotic drug |
| Definition (CSP) | semi-synthetic macrolide antibiotic; related to erythromycin. |
| Definition (MSH) | A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. |
| Definition (NCI) | An azalide, derived from erythromycin, and a member of a subclass of macrolide antibiotics with bacteriocidal and bacteriostatic activities. Azithromycin reversibly binds to the 50S ribosomal subunit of the 70S ribosome of sensitive microorganisms, thereby inhibiting the translocation step of protein synthesis, wherein a newly synthesized peptidyl tRNA molecule moves from the acceptor site on the ribosome to the peptidyl (donor) site, and consequently inhibiting RNA-dependent protein synthesis leading to cell growth inhibition and cell death. |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | D017963 |
| SnomedCT | 391804001, 387531004, 96034006 |
| English | Azythromycin, 1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))-, XZ-450, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentade, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentad, N-methyl-11-aza-10-deoxy-10-dihydroerythromycin A, azithromycin, Azithromycin, Azithromycin - chemical (substance), AZITHROMYCIN, Azithromycin [Chemical/Ingredient], 1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R, azythromycin, Azithromycin (product), Azithromycin (substance), Azithromycin - chemical |
| Swedish | Azitromycin |
| Czech | azithromycin |
| Spanish | Azithromycin - chemical, azitromicina (producto), azitromicina (sustancia), azitromicina, Azitromicina |
| Finnish | Atsitromysiini |
| Russian | AZITROMITSIN, АЗИТРОМИЦИН |
| Japanese | アジスロマイシン |
| Croatian | AZITROMICIN |
| Polish | Azytromycyna |
| French | Azithromycine |
| German | Azithromycin |
| Italian | Azitromicina |
| Portuguese | Azitromicina |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Clarithromycin (C0055856) |
|
|---|---|
| Definition (CSP) | semi-synthetic macrolide antibiotic; derivative of erythromycin. |
| Definition (MSH) | A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. |
| Definition (NCI) | An antibiotic drug used to treat infection. It belongs to the family of drugs called macrolides. |
| Definition (NCI) | A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms. Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression. (NCI04) |
| Definition (PDQ) | A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms. Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42308&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42308&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1054" NCI Thesaurus) |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | D017291 |
| SnomedCT | 387487009, 83999008 |
| English | 6-O-Methylerythromycin, Clarithromycin, Erythromycin, 6-O-methyl-, clarithromycin, clarithromycin (medication), CLARITHROMYCIN, Clarithromycin [Chemical/Ingredient], Clarithromycin (product), Clarithromycin (substance), CLARITH |
| Swedish | Klaritromycin |
| Czech | clarithromycin |
| Finnish | Klatritromysiini |
| Russian | KLARITROMITSIN, КЛАРИТРОМИЦИН |
| Japanese | クラリスロマイシン |
| Italian | 6-O-Metileritromicina, Claritromicina |
| Polish | Klarytromycyna |
| Spanish | 6-O-metileritromicina, claritromicina (producto), claritromicina (sustancia), claritromicina, Claritromicina |
| French | Clarithromycine |
| German | Clarithromycin |
| Portuguese | Claritromicina |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Zithromax (C0678143) |
|
|---|---|
| Definition (CHV) | brand name of azithromycin |
| Definition (CHV) | brand name of azithromycin |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | D017963 |
| English | zithromax [brand name], zithromax, Bayer Brand of Azithromycin Dihydrate, Pfizer Brand of Azithromycin Dihydrate, Mack Brand of Azithromycin Dihydrate, Azadose, Azithromycin Pfizer Brand, Azitrocin, Pfizer Brand of Azithromycin, Ultreon, Zitromax, Zithromax |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Biaxin (C0701281) |
|
|---|---|
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | D017291 |
| English | biaxin, Biaxin |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
telithromycin (C0907410) |
|
|---|---|
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C106791 |
| SnomedCT | 395260006, 410908003 |
| English | telithromycin (medication), telithromycin [Chemical/Ingredient], telithromycin, Telithromycin (product), Telithromycin, Telithromycin (substance), TELITHROMYCIN |
| Spanish | telitromicina (producto), telitromicina, telitromicina (sustancia) |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Ketek (C1452484) |
|
|---|---|
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C106791 |
| English | Aventis brand of telithromycin, Ketek |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |